Lean production of taste improved lipidic sodium benzoate formulations

Eur J Pharm Biopharm. 2014 Oct;88(2):455-61. doi: 10.1016/j.ejpb.2014.05.013. Epub 2014 May 21.

Abstract

Sodium benzoate is a highly soluble orphan drug with unpleasant taste and high daily dose. The aim of this study was to develop a child appropriate, individually dosable, and taste masked dosage form utilizing lipids in melt granulation process and tableting. A saliva resistant coated lipid granule produced by extrusion served as reference product. Low melting hard fat was found to be appropriate as lipid binder in high-shear granulation. The resulting granules were compressed to minitablets without addition of other excipients. Compression to 2mm minitablets decreased the dissolved API amount within the first 2 min of dissolution from 33% to 23%. The Euclidean distances, calculated from electronic tongue measurements, were reduced, indicating an improved taste. The reference product showed a lag time in dissolution, which is desirable for taste masking. Although a lag time was not achieved for the lipidic minitablets, drug release in various food materials was reduced to 2%, assuming a suitable taste masking for oral sodium benzoate administration.

Keywords: Electronic tongue; Food interaction; Hard fat; Melt granulation; Orphan drug; Sodium benzoate; Taste masking.

MeSH terms

  • Calorimetry, Differential Scanning
  • Chemistry, Pharmaceutical*
  • Lipids / chemistry*
  • Microscopy, Electron, Scanning
  • Pharmacokinetics
  • Sodium Benzoate / chemistry*
  • Solubility
  • Taste*
  • Tongue

Substances

  • Lipids
  • Sodium Benzoate